317 related articles for article (PubMed ID: 21820153)
1. Pediatric adrenocortical tumors: morphological diagnostic criteria and immunohistochemical expression of matrix metalloproteinase type 2 and human leucocyte-associated antigen (HLA) class II antigens. Results from the Italian Pediatric Rare Tumor (TREP) Study project.
Magro G; Esposito G; Cecchetto G; Dall'Igna P; Marcato R; Gambini C; Boldrini R; Collini P; D'Onofrio V; Salfi N; d'Amore E; Ferrari A; Bisogno G; Alaggio R
Hum Pathol; 2012 Jan; 43(1):31-9. PubMed ID: 21820153
[TBL] [Abstract][Full Text] [Related]
2. Weineke criteria, Ki-67 index and p53 status to study pediatric adrenocortical tumors: Is there a correlation?
Das S; Sengupta M; Islam N; Roy P; Datta C; Mishra PK; Banerjee S; Chaudhuri MK; Chatterjee U
J Pediatr Surg; 2016 Nov; 51(11):1795-1800. PubMed ID: 27567308
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of Wieneke criteria in assessing morphologic characteristics of adrenocortical tumors in children.
Chatterjee G; DasGupta S; Mukherjee G; Sengupta M; Roy P; Arun I; Datta C; Mishra PK; Banerjee S; Chatterjee U
Pediatr Surg Int; 2015 Jun; 31(6):563-71. PubMed ID: 25895073
[TBL] [Abstract][Full Text] [Related]
4. IGFII and MIB1 immunohistochemistry is helpful for the differentiation of benign from malignant adrenocortical tumours.
Schmitt A; Saremaslani P; Schmid S; Rousson V; Montani M; Schmid DM; Heitz PU; Komminoth P; Perren A
Histopathology; 2006 Sep; 49(3):298-307. PubMed ID: 16918977
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of Major Histocompatibility Complex Class II Expression in Pediatric Adrenocortical Tumors: A St. Jude and Children's Oncology Group Study.
Pinto EM; Rodriguez-Galindo C; Choi JK; Pounds S; Liu Z; Neale G; Finkelstein D; Hicks JM; Pappo AS; Figueiredo BC; Ribeiro RC; Zambetti GP
Clin Cancer Res; 2016 Dec; 22(24):6247-6255. PubMed ID: 27307598
[TBL] [Abstract][Full Text] [Related]
6. Adrenocortical tumors with myxoid features: a distinct morphologic and phenotypical variant exhibiting malignant behavior.
Papotti M; Volante M; Duregon E; Delsedime L; Terzolo M; Berruti A; Rosai J
Am J Surg Pathol; 2010 Jul; 34(7):973-83. PubMed ID: 20534995
[TBL] [Abstract][Full Text] [Related]
7. Weiss criteria in large adrenocortical tumors: a validation study.
Jain M; Kapoor S; Mishra A; Gupta S; Agarwal A
Indian J Pathol Microbiol; 2010; 53(2):222-6. PubMed ID: 20551521
[TBL] [Abstract][Full Text] [Related]
8. Adrenocortical neoplasms in young children: age as a prognostic factor.
Ahmed AA
Ann Clin Lab Sci; 2009; 39(3):277-82. PubMed ID: 19667412
[TBL] [Abstract][Full Text] [Related]
9. Myxoid adrenal cortical neoplasms.
Raparia K; Ayala AG; Sienko A; Zhai QJ; Ro JY
Ann Diagn Pathol; 2008 Oct; 12(5):344-8. PubMed ID: 18774497
[TBL] [Abstract][Full Text] [Related]
10. A clinicopathologic profile of adrenocortical tumors.
Upadhye PS; Desai MP; Colaco MP; Desai PB; Deshpande RK; Mokal RA
Indian Pediatr; 1997 Jun; 34(6):481-90. PubMed ID: 9357203
[TBL] [Abstract][Full Text] [Related]
11. Gene expression profiling of childhood adrenocortical tumors.
West AN; Neale GA; Pounds S; Figueredo BC; Rodriguez Galindo C; Pianovski MA; Oliveira Filho AG; Malkin D; Lalli E; Ribeiro R; Zambetti GP
Cancer Res; 2007 Jan; 67(2):600-8. PubMed ID: 17234769
[TBL] [Abstract][Full Text] [Related]
12. Adrenocortical tumors in children.
Ciftci AO; Senocak ME; Tanyel FC; Büyükpamukçu N
J Pediatr Surg; 2001 Apr; 36(4):549-54. PubMed ID: 11283875
[TBL] [Abstract][Full Text] [Related]
13. Transcription factors GATA-6, SF-1, and cell proliferation in human adrenocortical tumors.
Kiiveri S; Liu J; Arola J; Heikkilä P; Kuulasmaa T; Lehtonen E; Voutilainen R; Heikinheimo M
Mol Cell Endocrinol; 2005 Apr; 233(1-2):47-56. PubMed ID: 15767045
[TBL] [Abstract][Full Text] [Related]
14. Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults.
Faria AM; Almeida MQ
Mol Cell Endocrinol; 2012 Mar; 351(1):52-7. PubMed ID: 22019901
[TBL] [Abstract][Full Text] [Related]
15. Adrenocortical carcinomas: a 12-year clinicopathologic study of 15 cases.
Menon V; Krishnamurthy SV
Indian J Pathol Microbiol; 2006 Jan; 49(1):7-11. PubMed ID: 16625963
[TBL] [Abstract][Full Text] [Related]
16. Low expression of HLA-DRA, HLA-DPA1, and HLA-DPB1 is associated with poor prognosis in pediatric adrenocortical tumors (ACT).
Leite FA; Lira RC; Fedatto PF; Antonini SR; Martinelli CE; de Castro M; Neder L; Ramalho LN; Tucci S; Mastelaro MJ; Seidinger AL; Cardinalli IA; Yunes JA; Brandalise SR; Tone LG; Scrideli CA
Pediatr Blood Cancer; 2014 Nov; 61(11):1940-8. PubMed ID: 25156210
[TBL] [Abstract][Full Text] [Related]
17. Evaluating access to pediatric cancer care centers of children and adolescents with rare tumors in Italy: the TREP project.
Pastore G; De Salvo GL; Bisogno G; Dama E; Inserra A; Cecchetto G; Ferrari A; ;
Pediatr Blood Cancer; 2009 Aug; 53(2):152-5. PubMed ID: 19353626
[TBL] [Abstract][Full Text] [Related]
18. Matrix metalloproteinase type 2 expression in malignant adrenocortical tumors: Diagnostic and prognostic significance in a series of 50 adrenocortical carcinomas.
Volante M; Sperone P; Bollito E; Frangipane E; Rosas R; Daffara F; Terzolo M; Berruti A; Papotti M
Mod Pathol; 2006 Dec; 19(12):1563-9. PubMed ID: 16980949
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of MMP-1, MMP-8, MMP-9 serum levels in patients with adrenal tumors prior to and after surgery.
Kołomecki K; Stepień H; Bartos M; Narebski J
Neoplasma; 2001; 48(2):116-21. PubMed ID: 11478691
[TBL] [Abstract][Full Text] [Related]
20. High diagnostic and prognostic value of steroidogenic factor-1 expression in adrenal tumors.
Sbiera S; Schmull S; Assie G; Voelker HU; Kraus L; Beyer M; Ragazzon B; Beuschlein F; Willenberg HS; Hahner S; Saeger W; Bertherat J; Allolio B; Fassnacht M
J Clin Endocrinol Metab; 2010 Oct; 95(10):E161-71. PubMed ID: 20660055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]